thrombolysis Archives -

There’s been hardly any change in the use of clot-dissolving (thrombolytic) therapies for conditions like heart attack and

TargED Bio raises €39m for new clot-busting drug

https://pharmaphorum.com/news/targed-bio-raises-e39m-for-new-clot-busting-drug/

Boehringer Ingelheim’s latecomer antibody therapy for COVID-19 has been side-lined, as the company focuses its attention on its

Boehringer takes alteplase to phase 3 for COVID, but drops antibody

https://pharmaphorum.com/news/boehringer-takes-alteplase-to-phase-3-for-covid-but-drops-antibody/

Biogen has licensed a new drug from Japanese biotech TMS that it hopes could provide a big advance

Biogen bolsters ischaemic stroke pipeline with thrombolytic from TMS

https://pharmaphorum.com/news/biogen-bolsters-ischaemic-stroke-pipeline-with-thrombolytic-from-tms/

thrombolysis